ETTX

Entasis Therapeutics Holdings Inc.
ETTX

Overview Fund Activity
Delisted

ETTX was delisted on the 8th of July, 2022.

Back to rankings

30 hedge funds and large institutions have $19.6M invested in Entasis Therapeutics Holdings Inc. in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+8
Holders Change %
+36.36%
% of All Funds
0.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
7
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
Armistice Capital
New York
$7.16M
2
CCM
CAAS Capital Management
New York
$1.18M
3
Renaissance Technologies
Renaissance Technologies
New York
$491K
4
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
$123K
5
Vanguard Group
Vanguard Group
Pennsylvania
$201K

Top Sellers

1
NHAS
Novo Holdings A/S
Denmark
$2.35M
2
Blackstone Inc
Blackstone Inc
New York
$1.16M
3
SI
Sofinnova Investments
California
$2.07M
4
GIM
Granahan Investment Management
Massachusetts
$0
5
FM
Frazier Management
Washington
$408K
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$4K +$893 +461 +29%
BG
27
Bollard Group
Massachusetts
$3K -$9.47K -4,571 -76%
Millennium Management
28
Millennium Management
New York
$257 +$257 +125,848 New
GIM
29
Granahan Investment Management
Massachusetts
– -$340K -114,829 Closed
PAG
30
Private Advisor Group
New Jersey
– -$3K -1,000 Closed
1
2